This dedicated Phase 1–4 clinical trial facility provides scientific and ethical support for clinical research aimed at developing new drugs and establishing novel therapies.

We provide an optimal research environment for developing new anticancer drugs and establishing innovative therapies. Our tailored support system covers every stage, from first-in-human (FIH) and Phase 1 trials to large-scale Phase 3 studies.

As Korea's only dedicated pediatric outpatient clinical research facility, we provide a safe research environment tailored to pediatric participants.

Division of Pediatric Clinical Trials
Functions
  • As Korea's only dedicated pediatric outpatient clinical research facility, administers investigational products to pediatric participants and monitors adverse reactions
  • Collection, processing, and storage of research specimens
Facilities and Equipment
  • A total of 3 beds
  • Centrifuge
  • Refrigerator, low-temperature freezer, and ultra-low-temperature freezer

We provide consistent consultation throughout every stage of clinical research—including new drug development trials—from planning and conduct to results reporting.

Pharmacokinetics/Pharmacodynamics Lab
Functions
  • Consistent consultation from planning through conduct and results reporting for various clinical studies, including new drug development trials
  • Independent consultation in coordination with the Pharmaceutical Research Laboratory and the PMS and Multicenter Research Support Office